Page Title

Webinar Agenda

Welcome and introduction:
Cosmopole | Kamir

OPENING ADDRESS:

Aviad Tamir
Head of Life Sciences & Healthcare at Invest in Israel

Overview of the Healthcare Ecosystem in Israel

PRESENTATIONS:

Ayana Pharma | Gal Cohen,Executive Chairman

A pharmaceutical company focused on development of Liposomal Therapeutics for the treatment of cancer, waiting for an FDA approval.

MediWound | Boaz Gur-Lavie,Chief Financial Officer

A biotechnology niche specialty company, focused on devolping, manufacturing and globally commercializing innovative products designed to address unmet needs in the field of server burn and chronic wound management.

Galmed | Liat Hayardeny - Brueck Chief Scientific Officer

A clinical-stage biopharmaceutial company focused on the development of Aramchol™. Aramchol has the potential to be a disease modifying treatment for fatty liver disorders, including NASH.

Inretio* | Raviv Vine, CEO

Inretio is developing a medical device for ischemic stroke treatment. The devuce 'traps' the clot and retrieves it from the brain. The device improves the current procedure and protects the brain during the operation.

aVISI* | Nir Betser, CEO Founder

aVISI Pharma is developing a drug delivery for causes of visual impairment and blindness, making a clinically significant difference in patients' lives

*Funding recipients from the Israeli Innovation Authority